166 related articles for article (PubMed ID: 37220319)
21. Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas.
Bareke H; Ibáñez-Navarro A; Guerra-García P; González Pérez C; Rubio-Aparicio P; Plaza López de Sabando D; Sastre-Urgelles A; Ortiz-Cruz EJ; Pérez-Martínez A
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176035
[TBL] [Abstract][Full Text] [Related]
22. Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases.
Antonescu CR; Owosho AA; Zhang L; Chen S; Deniz K; Huryn JM; Kao YC; Huang SC; Singer S; Tap W; Schaefer IM; Fletcher CD
Am J Surg Pathol; 2017 Jul; 41(7):941-949. PubMed ID: 28346326
[TBL] [Abstract][Full Text] [Related]
23. Small Round Blue Cell Sarcoma Other Than Ewing Sarcoma: What Should an Oncologist Know?
Davis JL; Rudzinski ER
Curr Treat Options Oncol; 2020 Sep; 21(11):90. PubMed ID: 32875423
[TBL] [Abstract][Full Text] [Related]
24. Bone sarcomas of the head and neck in children: the St Jude Children's Research Hospital experience.
Daw NC; Mahmoud HH; Meyer WH; Jenkins JJ; Kaste SC; Poquette CA; Kun LE; Pratt CB; Rao BN
Cancer; 2000 May; 88(9):2172-80. PubMed ID: 10813731
[TBL] [Abstract][Full Text] [Related]
25. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
26. Round Cell Sarcomas: Newcomers and Diagnostic Approaches.
Nagy A; Somers GR
Surg Pathol Clin; 2020 Dec; 13(4):763-782. PubMed ID: 33183732
[TBL] [Abstract][Full Text] [Related]
27. Current approaches to management of bone sarcoma in adolescent and young adult patients.
Ingley KM; Maleddu A; Grange FL; Gerrand C; Bleyer A; Yasmin E; Whelan J; Strauss SJ
Pediatr Blood Cancer; 2022 Feb; 69(2):e29442. PubMed ID: 34767314
[TBL] [Abstract][Full Text] [Related]
28. The value of adjuvant chemotherapy in the management of sarcomas in children.
Donaldson SS
Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
[TBL] [Abstract][Full Text] [Related]
29. Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials.
Livingston JA; Hess KR; Naing A; Hong DS; Patel S; Benjamin RS; Ludwig JA; Conley A; Herzog CE; Anderson P; Meric-Bernstam F; Kurzrock R; Subbiah V
Oncotarget; 2016 Sep; 7(39):64421-64430. PubMed ID: 27486883
[TBL] [Abstract][Full Text] [Related]
30. Superficial sarcomas with CIC rearrangement are aggressive neoplasms: A series of eight cases.
Ko JS; Marusic Z; Azzato EM; Farkas DH; Van Arnam J; Seiwerth S; Fritchie K; Patel RM; Rubin BP; Billings SD
J Cutan Pathol; 2020 Jun; 47(6):509-516. PubMed ID: 32026485
[TBL] [Abstract][Full Text] [Related]
31. The 'other' bone sarcomas in Japan: a retrospective study of primary bone sarcomas other than osteosarcoma, Ewing sarcoma and chondrosarcoma, using data from the Bone Tumuor Registry in Japan.
Nagano A; Tsugita M; Nishimoto Y; Akiyama H; Kawai A
Jpn J Clin Oncol; 2021 Aug; 51(9):1430-1436. PubMed ID: 34105731
[TBL] [Abstract][Full Text] [Related]
32. [Interdisciplinary diagnostic and treatment of bone sarcomas of the extremities and trunk].
Andreou D; Hardes J; Gosheger G; Henrichs MP; Nottrott M; Streitbürger A
Handchir Mikrochir Plast Chir; 2015 Apr; 47(2):90-9. PubMed ID: 25897578
[TBL] [Abstract][Full Text] [Related]
33. Xenograft and genetically engineered mouse model systems of osteosarcoma and Ewing's sarcoma: tumor models for cancer drug discovery.
Sampson VB; Kamara DF; Kolb EA
Expert Opin Drug Discov; 2013 Oct; 8(10):1181-9. PubMed ID: 23844615
[TBL] [Abstract][Full Text] [Related]
34. Challenges of Systemic Therapy Investigations for Bone Sarcomas.
Nakano K
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408900
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.
Hung YP; Fletcher CD; Hornick JL
Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175
[TBL] [Abstract][Full Text] [Related]
36. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
[TBL] [Abstract][Full Text] [Related]
37. Mobile Spine Osseous Sarcoma: Descriptive Epidemiological Analysis Based on a National Population-Based Study.
Ebrahimpour A; Chehrassan M; Sadighi M; Azizmohammad Looha M; Karimi A; Raeisi A; Zali A; Akbari ME
Arch Iran Med; 2021 Aug; 24(8):629-635. PubMed ID: 34488331
[TBL] [Abstract][Full Text] [Related]
38. [What´s new in Ewing-like sarcoma family? Soft tissue and bone sarcomas with CIC/BCOR rearrangement. Review of the literature and first personal experience].
Kinkor Z; Grossmann P; Dubová M; Bludovský D; Černá A; Krsková L; Lhoták P
Cesk Patol; 2017; 53(4):175-180. PubMed ID: 29227121
[TBL] [Abstract][Full Text] [Related]
39. Ewing Sarcoma and the History of Similar and Possibly Related Small Round Cell Tumors: From Whence Have We Come and Where are We Going?
Kilpatrick SE; Reith JD; Rubin B
Adv Anat Pathol; 2018 Sep; 25(5):314-326. PubMed ID: 29911999
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy in the management of osteosarcoma and Ewing's sarcoma.
Schuetze SM
J Natl Compr Canc Netw; 2007 Apr; 5(4):449-55. PubMed ID: 17442235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
